Journal article
Mechanisms of chemotherapy‐induced muscle wasting in mice with cancer cachexia
Kate T Murphy, Kristy Swiderski, James G Ryall, Jonathan R Davey, Hongwei Qian, Séverine Lamon, Victoria C Foletta, Jennifer Trieu, Annabel Chee, Suzannah J Read, Timur Naim, Paul Gregorevic, Gordon S Lynch
JCSM Rapid Communications | Wiley | Published : 2022
DOI: 10.1002/rco2.50
Abstract
AbstractBackgroundCachexia is a debilitating complication of cancer characterized by progressive wasting and weakness of skeletal muscles that reduces quality of life and can compromise survival. Many anticancer treatments, such as chemotherapy, also cause muscle wasting, which impairs the response to treatment. Given that many cancer patients present with cachexia at the initiation of treatment, we investigated whether cachectic mice were susceptible to chemotherapy‐induced muscle wasting and to investigate contributing mechanisms, including the dysregulation of microRNAs (miRs).MethodsCachectic colon‐26 (C‐26) tumour‐bearing mice were given 5‐fluourouracil (5‐FU) chemotherapy or vehicle tr..
View full abstractRelated Projects (3)
Grants
Awarded by Cancer Council Victoria
Awarded by Victorian Cancer Agency
Awarded by National Health and Medical Research Council